Skip to content

AKBA

Akebia Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.97
−0.87%
Ask drillr
0
Insider buys (3m)
1
Insider sells (3m)
-$62.2K
Net value (3m)
+5.0%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 10, 2026Butler John P. · director, officer: CEO and PresidentM-Exempt350,000$0.63
Jul 1, 2026Ostrowski Erik · officer: SVP, CFO, CBO & TreasurerSale56,019$1.11
Jun 22, 2026ROGERS MICHAEL W · directorA-Award35,700$0.00
Jun 22, 2026FRIESON RON · directorA-Award35,700$0.00
Jun 22, 2026Wolf Myles · directorA-Award53,600$1.02
Jun 22, 2026ZUMWALT LEANNE M · directorA-Award35,700$0.00
Jun 22, 2026ZUMWALT LEANNE M · directorA-Award53,600$1.02
Jun 22, 2026ADAMS ADRIAN · directorA-Award35,700$0.00
Jun 22, 2026Smith Cynthia · directorA-Award53,600$1.02
Jun 22, 2026ROGERS MICHAEL W · directorA-Award53,600$1.02
Jun 22, 2026ADAMS ADRIAN · directorA-Award53,600$1.02
Jun 22, 2026FRIESON RON · directorA-Award53,600$1.02
Jun 22, 2026Wolf Myles · directorA-Award35,700$0.00
Jun 22, 2026Smith Cynthia · directorA-Award35,700$0.00
Apr 3, 2026Vickers Philip J. · directorA-Award214,400$1.41
Mar 5, 2026Butler John P. · director, officer: CEO and PresidentPurchase69,270$1.25
Feb 4, 2026Butler John P. · director, officer: CEO and PresidentSale96,065$1.39
Feb 4, 2026Burke Steven Keith · officer: SVP, Chief Medical OfficerSale25,375$1.39
Feb 4, 2026Butler John P. · director, officer: CEO and PresidentA-Award175,250$1.41
Feb 4, 2026Butler John P. · director, officer: CEO and PresidentSale46,660$1.39
Feb 4, 2026Burke Steven Keith · officer: SVP, Chief Medical OfficerSale21,582$1.39
Feb 4, 2026Malabre Richard C · officer: SVP, Chief Accounting OfficerSale13,382$1.39
Feb 4, 2026Grund Nicholas · officer: Chief Commercial OfficerSale53,585$1.39
Feb 4, 2026Rucci Carolyn M. · officer: SVP, Chief Legal OfficerSale27,544$1.39
Feb 4, 2026Grund Nicholas · officer: Chief Commercial OfficerSale31,244$1.39
Feb 4, 2026Rucci Carolyn M. · officer: SVP, Chief Legal OfficerSale25,382$1.39
Feb 4, 2026Malabre Richard C · officer: SVP, Chief Accounting OfficerSale36,142$1.39
Feb 4, 2026Ostrowski Erik · officer: SVP, CFO, CBO & TreasurerSale34,951$1.39
Feb 4, 2026Rucci Carolyn M. · officer: SVP, Chief Legal OfficerSale16,846$1.39
Feb 4, 2026Butler John P. · director, officer: CEO and PresidentSale114,891$1.39
Institutional positioning

13F filings over the trailing two quarters

New 36Increased 43Reduced 57Sold out 169
FilerActionSharesFiled
BLACKROCK, INC.Reduced18,693,296May 13, 2026
STATE STREET CORPReduced11,614,006May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position11,166,710May 15, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased6,452,252May 15, 2026
GOLDMAN SACHS GROUP INCIncreased4,706,437Mar 25, 2026
GOLDMAN SACHS GROUP INCReduced3,602,827May 15, 2026
CITIGROUP INCIncreased2,854,586May 11, 2026
BANK OF AMERICA CORP /DE/Increased2,763,362May 18, 2026
QUBE RESEARCH & TECHNOLOGIES LTDReduced2,395,215May 15, 2026
MILLENNIUM MANAGEMENT LLCIncreased2,384,713May 15, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position2,215,441May 8, 2026
CHARLES SCHWAB INVESTMENT MANAGEMENT INCReduced2,015,577May 15, 2026
NANTAHALA CAPITAL MANAGEMENT, LLCUnchanged2,000,000May 15, 2026
CITADEL ADVISORS LLCIncreased1,981,859Sep 2, 2026
NORTHERN TRUST CORPReduced1,945,586May 14, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 10, 2026